EGFR and lung carcinoma: For each geographical region (for example, each country or the 20 Cancer Alliance regions in England), EGFR-driven lung cancer incidence was calculated by multiplying the total lung cancer incidence by the EGFR mutation rate (as reported as a proportion out of 1) as follows: EGFR mutation lung cancer incidence = lung cancer incidence x EGFR mutation rate.